decision / active
Separate Product Evidence from Agent Capability
PAT improves reusable Agent capability; Quant product lines earn evidence through separate data, research, portfolio, risk, and execution gates.
Separate Product Evidence from Agent Capability
Decision
PAT remains the Agent Foundation. PAAT remains the Alpha research team. PENGYI-01 remains a product-research target supported by independent data, portfolio, risk, and execution ownership.
Revisit Trigger
Revisit only when reproducible domain benchmarks show that ownership or interfaces create measurable bottlenecks.